Introduction
Schafer et al. [1] showed, in a multicentre, multinational study of men with LUTS suggestive of benign prostatic obstruction (BPO) , that many urodynamic traces were dif®cult or impossible to interpret. Subsequent experience with a standardized urodynamic protocol showed a great improvement in the standard of the urodynamics carried out. A standardized urodynamic protocol is now a prerequisite in all studies investigating lower urinary tract dysfunction. In multicentre trials, a central evaluation at a quality-control centre (QCC) further contributes to the value of the trial [2] .
It is therefore of paramount importance that these data are of the highest possible quality to maximize the information available for analysis. In studies which use urodynamic endpoints, the use of a standardized urodynamic protocol with quality-control analysis of the tracings has become the norm. This protocol covers studies in both BPO and in storage dysfunction, i.e. either bladder overactivity (BOA, detrusor instability) or genuine stress incontinence (GSI). Methods, de®nitions and units conform to the standards recommended by the ICS, except where speci®cally noted [3] .
Trials of treatments for BPO
There are several outcome measures in trials for the treatment for BPO, e.g. the maximum¯ow rate (Q max ) measured by uro¯owmetry, or the detrusor pressure at maximum¯ow (p det Q max ) and Q max measured during pressure-¯ow studies (PFS). Q max and p det Q max are used in the assessment of the degree of obstruction and can be presented on an ICS nomogram . (Fig. 1) , and computed into a BOO index, (BOOI), equal to (p det Q max ± 2Q max ) [4] . The inclusion of patients in trials is often based on Q max and p det Q max , as they are used in the calculation of the BOOI: a BOOI of 20±70, representing mild to moderate obstruction, is one of the inclusion criteria in a recent BPO trial using an antimuscarinic drug to treat BOA.
The outcome measures for trials on storage dysfunction (GSI or detrusor instability) may include objective improvement in storage function (i.e. changes in bladder sensation), reduction in BOA, increased urethral competence, increased bladder capacity and improved compliance. In addition, any changes that may occur during voiding, the Q max , p det Q max , volume voided and postvoid residual volume (PVR) will be recorded.
Initial submission of specimen traces to the QCC
When the decision is made to have a central review of urodynamic traces at a QCC, then each of the proposed participating centres should submit specimen traces for initial assessment. The inclusion of centres should be based on this assessment.
To eliminate as many problems as possible before the start of the study, prospective investigators should be asked to read the urodynamic brochure and submit ®ve annotated urodynamic traces, including the storage and voiding phases, and ®ve annotated urine¯ow traces for BPO trials. The urodynamic traces should be annotated . ( Fig. 2) with; the zero level for intravesical pressure (p ves ), intra-abdominal pressure (p abd ), p det , urinary¯ow rate (Q) and volume (and with urethral pressure, p ura , if urethral are measurements are included); the vertical scaling for p ves , p abd , p det , Q and volume (and p ura if urethral measurements included); the horizontal scaling of time (if the chart paper runs faster during the voiding phase this should be indicated); the investigator's urodynamic measurements and comments. The¯ow traces should be annotated with . (Fig. 3) : the zero level for ow; the vertical scaling of¯ow, e.g. the level for 25 mL/ s; the horizontal scaling of time; and the investigator's opinion of Q max and voided volume
Urodynamic studies
Clinical management depends on an accurate diagnosis; when investigating patients with lower urinary tract dysfunction appropriate attention must be paid to precise urodynamic technique. This section deals with setting up the urodynamic equipment and ensuring a good quality urodynamic test. The equipment required consists of a urine¯ow meter, urodynamic machine, an infusion pump and pressure measuring equipment.
Most commercially available¯ow meters are essentially accurate but require regular calibration, normally achieved by the constant-¯ow calibration device supplied by the manufacturer. However, if no device is supplied then a home-made system can be used . (Fig. 4) . The gate clamp can be adjusted, by trial and error, until it gives a constant¯ow of 10 mL/s. This is calculated by using a stop watch to measure the time taken for a de®ned volume of 100 mL to be collected by the¯ow meter. If thē ow meter is not recording accurately, then the machine is adjusted according to the manual of instructions. If there are problems the manufacturer or agent should be contacted.
It is important that artefacts are excluded on urinarȳ ow traces; in the example in . Fig. 5 the¯ow meter indicates that the Q max was 15 mL/s, but this is a`spike' artefact and should be ignored. It has been shown that the¯ow rate estimated during the initial void of a male patient has a lower Q max than those during the second and subsequent voids. In addition, the initial voided volume may be low. This phenomenon is probably caused by the patient's lack of familiarity with the clinic environment. Thus at the screening visit in any study the patient should provide two voids with voided volumes of >150 mL, with the higher Q max used for inclusion/ exclusion from the study (e.g.o12 mL/s may be an exclusion criteria). A consistent PVR of >250 mL would exclude the patient from some studies; the PVR should be measured by ultrasonography after both¯ow tests. To prepare the patient for the¯ow tests the investigator can provide the patient with the following instructions. "Try to come to the clinic with your bladder full, as this will mean a shorter time at the hospital. You may like to have one or two drinks within the hour before your appointment. The¯ow test takes 1±2 h; it will show how much urine your bladder holds and at what speed it empties. When your bladder feels full, you will be asked to pass water into a specially adapted toilet. This will be repeated once or twice. Each time, after you have passed urine, we will see how well you have emptied your bladder by using an ultrasound test."
Cystometry
To determine the bladder volume during ®lling cystometry, it is necessary to pump¯uid (water or contrast media) into the bladder. Most pumps work on a peristaltic principle; some machines have an integral pump, which can be calibrated using the instructions in the urodynamic equipment manual. However, it is still wise to check the accuracy of the pump by assembling the infusion set and connecting its distal end to the ®lling catheter. The pump should then be started and the infusion rate checked using a stopwatch and a measuring cylinder. The pump should be set to deliver¯uid at 10± 60 mL/min, depending on the study.
The urodynamic assessments will require the machine to present individual traces giving information on p ves , p abd , p det (p ves xp abd ) and Q. Most machines produce both Fig. 2 . The annotation of traces: each trace should show zero and full-scale de¯ection for¯ow rate, pressure and volume. The patient should be asked to cough at the start of ®lling, every minute during ®lling and before and after voiding to check transmission of pressure, First desire to void, maximum cystometric capacity and maximum¯ow rate should also be indicated on the trace. a chart with the four traces displayed and a digital display for each measurement. For the detailed calibration of the machine the manual for the individual apparatus should be consulted. Both p ves and p abd are measured using transducers that convert a pressure wave in water into an electrical signal; p det is then calculated electronically within the machine by subtracting p abd from p ves . Pressure can be measured by external transducers connected by¯uid-®lled manometer lines to the catheters within the patient, or with solid-state catheter-tip transducers (where the transducer is mounted on the catheter).
Urodynamic investigation
There are three fundamental and vital steps to setting up the equipment in¯uid-®lled systems: (i) preparing and priming the transducers, transducer domes and connecting tubes; (ii) checking the calibration of the transducers (the transducer should be calibrated by the service engineer, unless the operator is con®dent in his/her ability); (iii) setting the zero and establishing the pressure reference level.
(i) The transducer includes a sterile dome which has to be ®lled with¯uid to allow pressure to be transmitted. . Figure 6a shows a typical arrangement of the transducer dome connected to two three-way taps, the tubing that connects to either the bladder or abdominal catheter, and a syringe. The syringe is used to¯ush sterile water through the system. The transducer can either be held horizontally or vertically. Before starting the investigation or checking the calibration, the system must bè primed' (Fig. 6a) , i.e.¯uid is¯ushed from the syringe through the transducer and into the connecting tubes, ensuring that there are no air bubbles in the system.
(ii) A 100-cm measure is required to check the calibration of the pressure transducers. Tap B is opened as shown in Fig. 6b ; the end of the manometer tube C is placed at the zero mark (ensuring that the tube is primed and that there are no air bubbles); the pressures are set to zero (on most machines there is an instruction to either zero or balance the transducers). The traces and digital value should read zero. The manometer tube is raised until the end C is at the level of the 100 cm mark; the traces and digital value should now read 100 cmH 2 O (Fig. 6c ). If this reading is incorrect, the service engineer should be consulted. After checking the calibration, the pressures are re-zeroed so that atmospheric pressure is being recorded from the side-arm B, allowing the zero and reference level to be set correctly (Fig. 6d) .
(iii) The ICS has published a technical report which has established the convention that`zero pressure is atmospheric pressure'. Zero is taken as the open end of the short side-arm of the three-way tap B attached to the transducer (Fig. 6d) . The ICS has also de®ned a reference level for external transducers and¯uid-®lled catheters as the superior edge of the symphysis pubis. Hence it essential to level the transducers to this reference point. The short arm of the three-way tap B is the appropriate point, which must be on the same horizontal level as the Solid-state micro-tip catheters are calibrated by zeroing at atmospheric pressure and placing the catheter into a column of¯uid to a depth of 100 cm; the trace and digital value should read 100 cmH 2 O. Alternatively, insert the catheter into a pressure chamber, zero at atmospheric pressure, then increase the pressure in the chamber to 100 cmH 2 O; the trace and digital value should then read 100 cmH 2 O. If the calibration is incorrect the service engineer should be contacted. These transducers can be dif®cult to calibrate unless the operator is fully conversant with the technique. Catheter-mounted (solidstate) transducers have an integral reference level and are unaffected by positional changes.
Catheters and catheterization
The use of catheters will vary according to individual studies. In general, the bladder catheter used (to measure p ves ) should be a 6 F dual-channel catheter, which can remain in the urethra throughout the study. If insertion of a 6 F catheter proves too dif®cult for the size of the prostatic urethra, an 8 F catheter may be used. If an 8 F catheter is used for the ®rst pressure-¯ow assessment, it should also be used for all subsequent assessments in that patient [5] . For male catheterization, a local anaesthetic jelly or a lubricant jelly should be used to facilitate the passage of the catheter.
The two-way catheter should be passed well into the bladder and ®xed to the penis, leaving no gap between the external urinary meatus and the point at which tape A/B . (Fig. 7) is attached to the catheter. The second piece of tape, C/D, should be applied to the shaft of the penis, ensuring that this does not obstruct the urethra. The key to success in ®xing the urethral catheter is to be sure that there is no loop of catheter between the external urinary meatus and the point of tape ®xation. If the above technique is used there should be few problems with the catheter being voided during the investigation. The same insertion technique is used for female catheterization; the catheter should be secured as closely as possible to the external urinary meatus to ensure that the catheter is not expelled during voiding. The rectal catheter (to measure p abd ) has a small hole in the balloon to allow air and¯uid to escape as the catheter is¯ushed through . (Fig. 8a) . The rectal catheter is passed through the anal canal into the rectum (in female patients it is possible to use the vagina to record abdominal pressure). The catheter should be advanced 10±15 cm from the anal verge to ensure that it is well within the rectal lumen. It is dif®cult to obtain good readings if the patient's rectum is full; hence, if during the rectal examination before urodynamics the rectum is noted to be full, then those patients should be asked to empty their bowels. As with the bladder catheters, to ensure ®xation the catheter is attached as close as possible to the anal canal. Dry the anal verge to remove all lubricant¯uid and attach with sticky tape so that as little catheter as possible is visible between the anus and the tape (Fig. 8b) .
Ensuring a high-quality recording from the patient
Before starting recording and after the patient is catheterized, both the bladder and rectal lines should be¯ushed once more, to ensure that all bubbles and leaks have been removed. The ®rst quality-control test, the cough test, is used to ensure that there is a proper subtraction (p ves ± p abd = p det ), as detrusor pressure change is fundamental to most urodynamic analyses. Before recording starts, the patient should be asked to cough and the p ves and p abd traces observed; there should be an equal rise in pressure during the patient's cough; the patient is then asked to cough at regular intervals during the investigation. The patient should be asked to produce a cough that gives a de¯ection of <100 cmH 2 O; this de¯ection should show a rapid increase to the peak and then a rapid fall, as shown in . Fig. 9a . On the p det line there may be a small biphasic peak, but this is not signi®cant; what is crucial is that the height of the spikes on the p ves and the p abd lines are identical. If the spikes are not identical (Fig. 9b ) then there may be bubbles or leaks, one or more of the catheters may be malpositioned, or there may be interference with the abdominal trace arising from faecal loading. All these points must be checked and the cough repeated until the proper pattern is observed.
Once the initial cough gives a good quality signal then the bladder can be ®lled; throughout bladder ®lling, the patient should be asked to cough every minute. If at any stage the quality deteriorates, then the investigation must be stopped and the cause of the poor pressure transmission investigated. Once the fault is corrected then ®lling can recommence.
After voiding, the patient must be asked to cough again to ensure that the catheters have not moved during micturition. Failure to show an equal transmission of pressure after voiding means that the results cannot be interpreted con®dently and the investigation needs to be repeated.
Filling and voiding cystometry
If ®lling and voiding cystometry is to be used in men, then before any urodynamic study, free-¯ow rates should be measured. This allows the PFS voiding to be assessed by comparison with the free¯ow rates. The patient is asked to empty his/her bladder as completely as possible, and the free¯ow rate and volume voided are recorded. The patient is then catheterized. The urine is tested by dipstick; if the dipstick test indicates a possible abnormality, then a urine sample is submitted for culture and to assess bacterial sensitivities. The PVR can be assessed by draining residual urine after the initial void, but in some studies the protocol may demand that the PVR is measured by ultrasonography, but not removed.
The pressure lines are prepared by connecting them to the transducer, ensuring that the reference level is correct, zeroing at atmospheric pressure, priming the lines (leaving the three-way taps in the working position, Fig. 6b,c) and checking the empty resting pressures. As a guide, the empty resting pressure (p ves and p abd ) should be 5±20 cmH 2 Before starting the investigation, the patient should be asked to cough to ensure that there is equal transmission from p ves and p abd , and that the resting pressures are within the acceptable range. If they are not then all parts of the system need to be re-assessed; catheters should be examined to ensure they have remained in place, the pressure lines¯ushed to ensure there are no air bubbles in the system, zeroes and baselines re-checked, and if necessary, catheters and/or transducer domes changed. When all pressures are recording accurately, the urodynamics can commence, remembering that the system should not be re-zeroed once the pressure lines are primed, connected to the patient and recording.
The bladder is usually ®lled either with the patient seated (females) or standing (males). If the patient has mobility or physical problems, the bladder may be ®lled with the patient lying down. The ®lling rate should be 10±60 mL/min and the infused¯uid, saline or contrast medium. If the bladder is very overactive it may be necessary to ®ll the bladder with the patient lying and to reduce the ®lling rate or even stop. If there is low compliance this may in part be due to ®lling too fast. Filling should be stopped for 2 min, when the pressure (p det ) stabilizes ®lling can recommence at a reduced rate. If the rate is changed or when the ®lling is stopped and restarted, there should be an indication on the trace. The patient must cough each minute and after voiding to ensure good quality control. The bladder is ®lled until the patient has a strong desire to void, but not over-full. The frequency-volume chart is a useful guide in determining the usual functional bladder capacity of the patient. The study might demand that the leak-point pressure (LPP) is assessed during ®lling. This may be at a ®xed volume, e.g. 200 mL (see below). If the patient is being assessed for incontinence, then it may be necessary to perform an exercise regimen at bladder capacity (depending on protocol), e.g. coughing when seated, and standing, walking, jumping and squatting/coughing (depending on mobility). Following this the patient voids, and is asked to cough after voiding to check that the catheters are in place and that pressures are recording accurately.
In many studies, and ideally in all investigations, a second ®ll/void cycle should be assessed. In this case, the bladder is not emptied after the ®rst ®ll/void; the technique for the second ®ll and void should be identical to the ®rst. At the end of the study, after voiding, the catheter is used to empty the bladder and the residual volume recorded.
Measurements during ®lling
Depending on the study, these comprise: ' The empty and full resting pressure (p det ) ' The volume at the ®rst desire to void, strong desire to void, urgency and bladder capacity; the maximum cystometric capacity is either the volume infused or the volume voided (plus any residual urine), whichever is the greater. ' The bladder capacity at the ®rst unstable contraction (if any) ' The bladder volume at each leakage episode, the cause, i.e. BOA or GSI, and the volume leaked. ' The compliance, calculated as the volume infused divided by the change in pressure for the volume infused), e.g. if the volume infused=400 mL, the empty resting pressure (p det ) is 5 cmH 2 O, and the pressure at capacity (p det ) is 25 cmH 2 O, then the compliance is 400/(25x5)=20 mL/cmH 2 O. 
Measurements during voiding

Urethral function studies
The two common methods used to assess urethral function are urethral pressure pro®les (UPPs) and leakpoint pressures (LPPs) Traces can be obtained for both and should be annotated appropriately. For UPPs, the urethral closure pressure (UCP) depends on the subtraction of bladder pressure (p ves ) from urethral pressure (p ura ). The pressure recording used should indicate p ura , p ves and UCP. For LPPs, the exact time of leakage should be marked on the tracing and the pressure recording used should be indicated, i.e. p ves for the Valsalva LPP (VLPP), p abd for the abdominal LPP (ALPP) and p det for the detrusor LPP (DLPP) Urethral pressure pro®le catheters (using the Brown and Wickham technique) should be no larger then 10 F, with two opposed eye-holes 5 cm from the tip. A triplelumen catheter, which allows the measurement of p ves and p ura and which also has a ®lling line, can be used. With microtip catheters, one or more transducers are mounted on the catheter, thus allowing p ves and p ura to be recorded simultaneously.
The UPPs are obtained with the patient supine; the bladder is empty or contains a standard volume, e.g. 100 or 200 mL. For the Brown and Wickham technique the UPP catheter is introduced and connected via a three-way tap to the infusion pump and transducer (. Fig. 10 ). Fluid is¯ushed into the catheter from the transducer and the infusion pump set to 2 mL/min. The system should be checked for air bubbles and the patient asked to cough to ensure that there is good transmission of pressure. The catheter is then withdrawn at 1 mm/s; at least two successive measurements should be taken (two further pro®les should be measured if the ®rst two pro®les differ by > 10%).
Urethral pressure measurements
Variables measured for the female UPP (. Fig. 11a ) are the maximum urethral pressure (MUP), the maximum urethral closure pressure (MUCP, calculated as MUP ± p ves ), and the functional urethral length (FUL). For the male UPP (Fig. 11b) , the measurements are MUP, MUCP and prostatic length (PL). The withdrawal speed and time scale must be recorded by the investigator.
Method and measurement of leak point pressure (LPP)
In stress±incontinent patients, leak point pressure can be recorded as abdominal leak point pressure (ALPP) or valsalva leak point pressure (VLPP) depending on the aims of the study.
Abdominal leak point pressure (ALPP) ' The bladder is ®lled to 200 mL with the patient sitting. ' Only the abdominal catheter is left in situ. ' A valsalva manoeuvre is performed whilst the patient observes the abdominal pressure on the monitor or trace. ' The patient is asked to gradually increase the abdominal pressure whilst the investigator checks for leakage. The abdominal pressure at which leakage occurs is recorded and marked on the trace. ' The test is performed twice and the lowest pressure at which leakage occurs is taken as the Abdominal Leak Point Pressure (ALPP).
Valsalva Leak Point Pressure (VLPP) ' The bladder is ®lled to 200 mL, with the patient sitting. ' Using an aneroid pressure gauge, the patient makes a seal around the mouthpiece with her lips. She is asked to blow into the mouthpiece (while relaxing her pelvic oor) and increase the pressure to 10 mmHg while the clinician looks for urinary leakage. ' If leakage is not demonstrated at this level, the patient is asked to increase the reading to 20, 30 mmHg until leakage is observed. The pressure gauge helps to show the patient how to increase the abdominal pressure. ' If leakage does not occur, then the patient may be able to achieve higher pressures without blowing into the gauge. The patient is shown the recording representing p ves on the trace or monitor (the digital reading may be used) and is asked to increase p ves in increments of 20 cmH 2 O, by straining, holding the pressure for 5 seconds.
' Alternatively, the patient can be asked to gradually increase p ves , by straining: in this situation either video is required or the investigator must view the external meatus to precisely time leakage. If, using any of these methods, leakage is not observed, the bladder is then ®lled in increment of 100 mL and the process is repeated, until capacity. 
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' The VLPP is the minimum increase in total bladder pressure pves that causes leakage in the absence of a detrusor contraction. ' The position of the patient must be noted, sitting up, semi recumbent etc.
Detrusor Leak Point Pressure (DLPP) Detrusor leak point pressure (DLPP) has been used to assess urethral function in relation to bladder compliance in neurogenic patients. DLPP is the detrusor pressure at which leakage ®rst occurs around a ®lling catheter. The position of all leak point pressures must be clearly indicated on the trace by the investigator.
Principles and procedure for the central review of urodynamic data
Investigator's procedure
Originals or copies (an original version should remain at the site) of traces will be sent to the central reviewer, for examination after each patient visit. Traces should not be faxed, as the quality is inadequate. Each trace should be identi®ed by a study number, the investigator, a subject number (e.g. hospital number), visit date, visit number (1±10) and assessment number (e.g. ®rst ®ll/ void). Urodynamic data forms should be completed, containing both the original results (generated by the urodynamic equipment) and corrected values resulting from a review of the traces by the original investigator. A copy of the form, together with the trace (or good-quality photocopy) should be sent to the QCC.
The examiner will review the trace and complete his/ her part of the urodynamic data form (and enter the data onto a database if required). The completed form will be returned to the investigator for information and storage in the study ®le. All traces must contain the scaling on the x-and y-axis. Any problems/dif®culties should be recorded and will be considered by the examiner.
There should be a short questionnaire (see Appendix) for all urodynamic studies, including urethral function studies, which all investigators must complete, giving details of any deviation from the study protocol and information on the position of the patient during ®lling, voiding and the UPPs. This should be attached to each trace that is sent for central review.
Urodynamic review
The following rules are typical for a central review of uro¯owmetry. For traces with smooth curves with no signi®cant artefacts affecting the Q max values, the original value given by the free-¯ow equipment will be accepted as the result. Traces where the Q max value is in¯uenced by artefacts will be measured again using a ruler. The examiner will indicate the place on the curve where the Q max value is measured by drawing vertical and horizontal lines on the free¯ow trace. The value is given to the nearest 1 mL/s (Fig. 5) .
Traces with no automatic output from the free-¯ow equipment will be measured using a ruler, with the examiner adding indications as above. In case of doubt, only peaks that last for at least 2 s will be considered as true Q max values. If the examiner decides that a certain trace cannot be properly examined because of poor readability or because it is not available for central review, the results will be excluded. Traces which for any reason are considered to be unreliable may be withdrawn by the examiner, the reason being stated. A completed central review form for each trace will be returned to the investigator for ®ling in the study ®le.
Cystometry procedure
The following measurements are usually those subject to central review, and all urodynamic traces will be measured again according to the grid on the paper or with a ruler by the examiner, who will indicate the position on the traces of the following measurements:
Filling cystometry: empty resting pressure (p det ), volume at ®rst involuntary contraction, maximum cystometric capacity, pressure at maximum cystometric capacity (p det ), compliance, leakage volume caused by involuntary detrusor contraction, and/or GSI. If the empty resting pressure (p det ) is outside the range x5 to + 10 cmH 2 O the recording will be rejected unless there is a reasonable explanation. The volume at the start of the ®rst involuntary contraction (the contraction must be o 5 cmH 2 O) must be noted, whether this results in leakage or not. For consistency at central review, this will be the ®rst involuntary contractions o 5 cmH 2 O, measured as the increment above the empty resting pressure (p det ) and the volume at which this occurs will be either the volume infused or the volume voided plus residual urine, whichever is the greater.
The maximum cystometric capacity is the bladder volume when infusion is terminated, in response to the patient's experience of a`strong desire to void' or`urgent desire to void' or when further ®lling causes leakage and there is no further increase in cystometric capacity (stated as v cap ).
Voiding cystometry: According to the protocol, some or all the following measurements will be checked; Q max , p det Q max , p det open and p det min void, and in men the BOOI, the BCI and the BVE%. Q max will be measured according to the procedure for evaluating free-¯ow rates.
If the same Q max is attained more than once, or if it is sustained for a period of time, then the point of p det Q max is taken to be where the detrusor pressure has its lowest value for this¯ow rate [6] . A time delay of 0.5±1.0 s is assumed; this represents the time taken for urine to reach the¯owmeter.
In controlled situations, pressures can be adjusted. Firstly, when the initial p det (i.e. the p det at the start of ®lling) is above or below the baseline all p det measurements can be measured as an increment above the initial p det reading (which must be in the range x5 to +10 cmH 2 O). This means that if the initial p det is +5 cmH 2 O and the p det Q max is 95 cmH 2 O, p det Q max would be corrected to 90 cmH 2 O. This pragmatic decision ensures consistency of analysis technique, because p det is totally dependent on the accurate recording of p ves and p abd which cannot be guaranteed. Secondly, if p abd decreases during voiding and cannot be corrected, then p det will be adjusted to take account of this.
Urethral pressure pro®les
The readings will be taken from the reproducible pro®les and therefore not the highest or lowest but the estimated mean of two similar pro®les. The withdrawal speed and time scale must be indicated on the trace. The MUP will be measured from the baseline to the highest part of the curve, the MUCP as MUP ± p ves and the urethral length as in Fig. 11a,b .
Leak point pressure
The ALPP and VLPP will be the minimum increase in p abd and p ves , respectively, to cause leakage; the LPPs must be clearly marked on the trace.
Ineligible recordings
Traces which for any reason are considered to be invalid may be withdrawn by the examiner with a reason stated. If a particular trace is withdrawn because of a problem during voiding, all voiding measurements will be considered invalid. Traces will be disquali®ed when: technical failures occur, e.g. if the catheters measuring either p ves or p abd are voided or displaced; traces go`off scale' during voiding and cannot be interpreted; if there is no¯ow trace during voiding cystometry; if traces are of poor quality and/or if there is inadequate transmission of pressure, and are considered by the examiner to be unreadable. In cases where additional information is required, the central reviewer will contact the responsible investigator.
Final decisions
If there are large discrepancies among the assessment of the QCC, the ®nal review and the investigator's assessment, the traces will be reviewed again, with the ®nal judgement being given by the QCC.
Conclusions
A standard urodynamic protocol for any clinical trial that uses urodynamic measurements as either inclusion criteria or outcome measures, enhances the quality of the data obtained. The central review of urodynamic data by a QCC further enhances the value of the data by providing a single standard of interpretation. The overall quality of data in any trial can be further improved by selecting for participation only those centres whose traces submitted before the trial begins are of the highest quality. There are ethical issues around ensuring the highest quality of data, as it will reduce con®dence intervals and thereby increase the power of the study, necessitating fewer participants. 
Questionnaire
